I

Enrichment & HALEU

Centrus runs the only NRC-licensed US HALEU cascade; Western SWU is essentially two suppliers plus a Russian import ban with waivers expiring.

The Western world relies on a handful of facilities to turn natural uranium into reactor fuel, and the United States owns almost none of that capacity. Enrichment — measured in separative work units (SWU) — is the narrowest physical link in the nuclear fuel chain, and the high-assay variant (HALEU, enriched to just under 20% U-235) that every advanced-reactor design needs has almost no Western supply at all. This is the purest chokepoint in the vertical.

Who owns it

The commercial enrichment cartel is effectively four entities: Russia's Rosatom (the low-cost incumbent and roughly 40-45% of global SWU), Urenco (UK/Dutch governments plus Germany's E.ON and RWE — privately held, not listed), France's Orano (state-owned), and now the United States' re-emerging domestic capacity. The only US-listed pure play is Centrus Energy (LEU), which operates the only NRC-licensed HALEU cascade in the country — sixteen centrifuges at Piketon, Ohio, enriching to 19.75%. The would-be disruptor is laser enrichment via Global Laser Enrichment, 51% owned by Australia's Silex Systems (OTCQX: SILXY) and 49% by Cameco (CCJ), which is commercial lead and holds an option to 75%.

What breaks it

The binding constraint is the Russian dependency that policy is trying to sever. The Prohibiting Russian Uranium Imports Act bans Russian LEU but grants waivers that terminate no later than January 1, 2028. After that, every Western utility and advanced-reactor developer competes for SWU that two non-Russian commercial suppliers (Urenco, Orano) and a still-tiny Centrus can produce. HALEU is worse: until Centrus's Piketon line, no US-owned plant had enriched uranium since 2013. The chokepoint is physical (centrifuge cascades take years to build) and licensed (the NRC is the gatekeeper), which is why the catalyst tape is the docket and the DOE award calendar, not press releases.

What forces the reprice

Government money is now flowing into the bottleneck. On January 6, 2026 the DOE awarded HALEU/LEU task orders worth up to $2.7B: $900M each to Centrus (Piketon HALEU), General Matter (Paducah HALEU), and Orano (Oak Ridge LEU), plus $28.5M to GLE. The Centrus base task order runs up to $1.07B with options to expand Piketon, with first new capacity in 2029 toward a 96-cascade buildout, and on December 19, 2025 Centrus began industrial-scale centrifuge manufacturing in Oak Ridge. The reprice mechanism: each signed DOE task order and NRC license action converts a policy-deadline narrative into contracted, balance-sheet-backed capacity — and the 2028 waiver cliff is a hard date that pulls demand forward.

Be honest about size and earliness

Only one name here has real revenue. Centrus reported $76.7M of Q1 2026 revenue and a $3.9B backlog extending to 2040 — but that backlog is still mostly its legacy LEU trading book (buying SWU from Russia/Orano and reselling), not yet domestic enrichment, and Q1 LEU-segment SWU volume actually fell 47% year over year. The HALEU contract is DOE-funded demonstration economics, not a commercial market. Silex is pre-revenue at the enrichment line: its reported revenue is milestone payments from GLE, and it posted an A$17.9M half-year loss; GLE's Paducah plant has first operation targeted around 2030, with full capacity later in the decade. Cameco's GLE stake is a rounding error against its uranium-mining and Westinghouse earnings. General Matter has zero revenue and an unbuilt plant — a venture call option on a license and a DOE milestone contract. Treat SILXY and CCJ as optionality on the technology, not the enrichment cash flows; treat Centrus as the only name where the chokepoint already touches the income statement, and even there the domestic enrichment thesis is a 2029+ story being pre-funded by Washington. This is a real physical bottleneck with a hard 2028 policy catalyst, but the equity universe is one revenue-generating incumbent surrounded by call options.

Who owns the choke

CCJcore

Cameco Corporation

$66.73-5.7%

The West's most diversified nuclear fuel-cycle name: tier-one uranium mines (McArthur River/Key Lake, Cigar Lake), Port Hope UF6 conversion, 49% of Global Laser Enrichment (option to 75%), and 49% of Westinghouse (fuel fabrication + AP1000). 2026 own-share uranium guidance ~19.5–21.5M lb U3O8 on an investment-grade balance sheet.

Bull
The West's most diversified fuel-cycle name owns tier-one mines, Port Hope conversion, 49% of laser enrichment and 49% of Westinghouse, capturing the chokepoint at every link.
Bear
Enrichment and Westinghouse stakes are minority equity-method positions, so much of the fuel-cycle optionality is diluted against the core uranium-mining earnings.

[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13]

GENERALMATTERspeculativeprivate

General Matter

exposure via no listed vehicle

Venture-backed US enrichment startup (Founders Fund, Peter Thiel, IQT) awarded a $900M, 10-year milestone-based DOE IDIQ contract on Jan 6, 2026 to build HALEU enrichment capacity at the former Paducah Gaseous Diffusion Plant in Kentucky. Plans a ~$1.5B facility targeting enrichment by the end of the decade; currently pre-revenue with no operating plant.

Bull
General Matter's $900M DOE HALEU contract and planned Paducah enrichment facility position this Founders Fund-backed startup to help break Russia's enrichment grip by the decade's end.
Bear
Private, pre-revenue and with no operating plant, General Matter is a venture call option on a milestone contract and an unbuilt facility, with no listed access.

[1] [2]

LEUcore

Centrus Energy Corp.

$99.17-4.4%

Operates the only NRC-licensed US HALEU cascade (16 centrifuges enriching to 19.75% at Piketon, Ohio), with cumulative HALEU output now above 1.6 metric tons. Reported Q1 2026 revenue of $76.7M and a $3.9B backlog extending to 2040; the DOE's January 2026 enrichment package included a Centrus task order of $900M (up to $1.07B with options) to expand Piketon, with first new capacity targeted for 2029. Uplisted from NYSE American to NYSE on Dec 4, 2025.

Bull
Centrus runs the only NRC-licensed US HALEU cascade, has a $3.9B backlog to 2040, and won a $900M DOE Piketon expansion, the sole enricher where the chokepoint touches earnings.
Bear
Most backlog is the legacy LEU trading book where Q1 SWU volume fell 47%, and domestic enrichment economics are a DOE-funded 2029+ story.

[1] [2] [3] [4] [5] [6] [7] [8] [9]

SILXYwatch

Silex Systems Limited (ADR)

$9.82-6.7%

Australian licensor of SILEX laser enrichment technology; owns 51% of Global Laser Enrichment (GLE), which achieved TRL-6 third-party validation on Oct 23, 2025. GLE's Paducah Laser Enrichment Facility license application was docketed by the NRC on Aug 4, 2025; GLE received a $28.5M DOE award on Jan 6, 2026. Silex reported a ~A$17.9M H1 loss (Feb 2026) with revenue driven by a $7.6M GLE milestone payment.

Bull
Silex owns 51% of Global Laser Enrichment, which hit TRL-6 validation and docketed its Paducah license, plus a $28.5M DOE award, positioning it as enrichment's would-be disruptor.
Bear
Silex is a pre-revenue OTC ADR whose income is GLE milestone payments, posting an ~A$17.9M half-year loss with Paducah first operation only around 2030.

[1] [2] [3]

Catalyst calendar

  • 2026-09-30NRC final Environmental Impact Statement for GLE's Paducah Laser Enrichment FacilityhighCompleting the EIS (NRC-targeted Sept 2026) is a gating regulatory step toward licensing the only Western laser-enrichment plant, de-risking the longer-dated disruption of the SWU chokepoint for Silex and Cameco.
  • 2027-01-31NRC Safety Evaluation Report for GLE Paducah facility (anticipated)highThe SER is the safety-side prerequisite to an NRC construction-and-operation license for laser enrichment; its completion would clear the path to a build decision on a second-source enrichment technology.
  • 2028-01-01Russian LEU import waivers terminate (Prohibiting Russian Uranium Imports Act)highHard statutory date after which no Russian-uranium import waivers can be granted, forcing Western utilities onto a constrained non-Russian SWU base and directly tightening the enrichment chokepoint.
  • 2026-08-04Centrus Energy Q2 2026 earningsmediumFirst print after the Nov 2025 $900M DOE task order and Dec 2025 centrifuge-manufacturing launch; watch domestic-enrichment capex pace and HALEU/LEU backlog mix, the heart of the chokepoint thesis.

View these names in the dashboard →